Search Results 91-100 of 16929 for citrulline loading phase

  1. CATALINA-2: A Clinical Study Of TORL-1-23 In Platinum-resistant Ovarian Cancer.

    A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer. Participation eligibility. Participant eligibility ...

  2. A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) - Mayo Clinic

    A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory ...

  3. Trial of TRC105 and Sorafenib in Patients With HCC - Mayo Clinic

    About this study. The purpose of the phase 1b portion is to evaluate safety and tolerability and determine a recommended phase 2 dose for TRC105 when added ...

  4. Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. A Study of Intrathecal SHP611 in Participants With Late Infantile Metachromatic Leukodystrophy - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  6. Impact Of Estradiol Addback - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    Below are current clinical trials. 29 studies in Obstetrics and Gynecology (open studies only). Filter this list of studies by location, status and more.

  8. Hematology - Clinical trials

    The study will include a Phase 1 part to determine the recommended dose of JCAR017 monotherapy in subjects with relapsed or refractory CLL or SLL, followed by a ...

  9. First-in-Human Study of KO-947 in Non-Hematological Malignancies - Mayo Clinic

    This phase 1 first-in-human (FIH) dose escalation study will determine the maximum tolerated dose (MTD) of KO-947 in subjects with locally advanced unresectable ...

  10. PK and Safety of Paclitaxel Injection Concentrate for Nano-dispersion Alone and in Carboplatin Combination - Mayo Clinic

    This is a phase I study of PICN alone and in combination with carboplatin and consisting of 2 sequential parts. Part A will characterize the pharmacokinetic ...